Table 2.

SUCRA of LVEF, LVEDD, LVESD, NYHA, and HR rate

Treatment	LVEF		LVEDD		LVESD		NYHA		HR
	SUCRA	RANK	SUCRA	RANK	SUCRA	RANK	SUCRA	RANK	SUCRA	RANK
Control	0.14	22	0.14	19	0.16	11	0.09	19	0.18	14
l-Thyroxine	0.68	6	0.74	6	0.90	2	0.77	5	0.60	8
Ivabradine	0.29	17	0.81	1	0.94	1	0.82	4	0.96	1
DIP	0.24	18					0.10	18
Trimetazidine	0.83	3	0.47	8	0.65	4	0.95	1	0.16	15
Perhexiline	0.14	21					0.45	11
Carvedilol	0.92	1	0.78	4			0.62	7	0.78	2
Metoprolol	0.65	9	0.39	12			0.62	8	0.69	6
Rosuvastatin	0.23	19					0.16	16
n-3 PUFAs	0.47	14	0.37	15	0.46	6			0.41	9
Verapamil	0.92	2	0.78	3
Atorvastatin	0.38	16	0.76	5	0.72	3	0.33	15
LMWH	0.70	5	0.38	13	0.43	7	0.53	9
Nebivolol	0.65	8	0.41	11	0.25	8	0.37	14	0.38	10
Amiodarone	0.16	20	0.31	17			0.51	10
Cerivastatin	0.55	11
Simvastatin	0.57	10					0.41	13	0.63	7
Spironolactone	0.41	15					0.73	6
Pentoxifylline	0.83	4	0.37	14	0.60	5	0.90	2	0.27	11
rhGH	0.11	23	0.41	10					0.20	12
Diltiazem	0.65	7	0.51	7	0.19	10	0.42	12	0.20	13
Enalapril	0.48	13	0.31	18					0.75	4
Bucindolol	0.50	12	0.81	2			0.83	3	0.78	3
Bevantolol			0.31	16					0.70	5
Captopril									0.01	16
Coenzyme Q10			0.43	9	0.20	9	0.12	17

SUCRA, surface under the cumulative ranking curve